comparemela.com

Latest Breaking News On - Sweta adatia - Page 2 : comparemela.com

Brain fog and insomnia common in Covid long-haulers

health problems , said doctors treating “long-haulers” at a specialist UAE clinic. Insomnia, depression and chronic fatigue were some of the long-term conditions reported by patients receiving care at RAK Hospital in Ras Al Khaimah. Despite recovering from Covid, about 30 per cent of patients continued to suffer with symptoms, which were recorded as part of the hospital’s online Covid rehabilitation programme. People have reported not feeling like themselves, experiencing confusion and short-term memory loss Dr Sweta Adatia Chronic fatigue was reported by 47.5 per cent to be the most persistent complaint, with more than a third experiencing sleep problems. More than a quarter reported “brain fog” or confusion, and 32.5 per cent showed signs of depression.

UAE: Man in semi-coma springs back to life after surgery

UAE: Man in semi-coma springs back to life after surgery Staff Report/Ras Al Khaimah Filed on April 9, 2021 Dr Tinku Jose Kurisinkal with the patient and a staff member of RAK Hospital. Patient is fully conscious and is able to walk with support following difficult medical procedure. When a 45-year-old Ras Al Khaimah-based Indian businessman experienced an episode of dizziness and imbalance, little did he know that it was a prelude to a rare, massive cerebellar stroke he was to face two days later. The cruel, life-threatening stroke could have taken his life or disabled him forever, but he was saved in time by a timely surgery performed on him by team of doctors at RAK Hospital.

New therapy to treat migraine headaches introduced in the UAE

Dubai: Are you someone who suffers from throbbing headaches, with a specific smell or light triggering nausea, vomiting and a debilitating pain in the head periodically? It is likely that you are a victim of migraine, which has been recognised as the second-highest cause of disability in the UAE with one in five individuals suffering from it. Conventionally, migraines were being treated with painkillers, anti-depressants, anti-epileptic drugs and tryptamine-based drugs, with little hope of reducing the intensity or frequency. Now you need not suffer any more. A new treatment called the Anti-CGRP (calcitonin gene-related peptide) targets the pain specifically caused by the CGRP neuropeptide by inhibiting it, thereby mitigating the pain and managing it to near minimum. The therapy not only reduces the periodicity and intensity of these headaches, but also helps you manage it so effectively that migraine patients suffer no loss of productivity at work or enjoyment hours during leisure.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.